Format

Send to

Choose Destination
Sci Rep. 2016 Jan 20;6:19391. doi: 10.1038/srep19391.

Assessing the utility of Xpert(®) MTB/RIF as a screening tool for patients admitted to medical wards in South Africa.

Author information

1
Clinical and Biomedical Tuberculosis Research Unit, Medical Research Council, South Africa.
2
Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, USA.
3
KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), South Africa.
4
Division of Global Health Equity, Brigham and Women's Hospital, USA.
5
Department of Epidemiology, Harvard School of Public Health, USA.
6
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, South Africa.
7
Department of Medicine, Edendale Hospital, South Africa.

Abstract

Many hospital inpatients in South Africa have undiagnosed active and drug-resistant tuberculosis (TB). Early detection of TB is essential to inform immediate infection control actions to minimize transmission risk. We assessed the utility of Xpert(®) MTB/RIF (GeneXpert) as a screening tool for medical admissions at a large public hospital in South Africa. Consecutive adult patients admitted to medical wards between March-June 2013 were enrolled; sputum specimens were collected and tested by GeneXpert, smear microscopy, and culture. Chest X-rays (CXRs) were conducted as standard care for all patients admitted. We evaluated the proportion of patients identified with TB disease through each diagnostic method. Among enrolled patients whose medical charts were available for review post-discharge, 61 (27%) were diagnosed with TB; 34 (56% of diagnosed TB cases) were GeneXpert positive. When patients in whom TB was identified by other means were excluded, GeneXpert yielded only four additional TB cases. However, GeneXpert identified rifampicin-resistant TB in one patient, who was initially diagnosed based on CXR. The utility of GeneXpert for TB screening was limited in an institution where CXR is conducted routinely and which serves a population in which TB and TB/HIV co-infection are highly prevalent, but it allowed for rapid detection of rifampicin resistance.

PMID:
26786396
PMCID:
PMC4726405
DOI:
10.1038/srep19391
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center